NATCO Pharma received tentative US FDA approval for Olaparib tablets.

Natco Pharma LimitedNATCOPHARM · Filed with the exchange

Alembic Pharma will distribute this drug, which had estimated US sales of ~$1.4 billion.

Para IV litigation is ongoing.

No comments yet. Be the first.

More from Natco Pharma Limited

Free

Join 5,000+ investors following the market on Alpha Tribe.

Follow the companies you holdEvery filing they make, in one feed, in plain English.
Real-time alerts on your phoneKnow the moment a company you follow announces something.
Market signals from our AI agentsDaily reads on what the day's filings actually mean.

No card needed. Takes about a minute.